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license (http://creativecommons.org/Abstract Objectives: Left ventricular diastolic dysfunction (LVDD) is associated with a vari-
ety of medical conditions. Left ventricular hypertrophy (LVH) is one of the most common ab-
normalities that induce LVDD. However, it is unclear whether LVH is a predictor of future LVDD
deterioration that leads to diastolic heart failure in patients who already have mild-to-
moderate LVDD. In this study, we investigated the effect of LVH on LV diastolic function in
mild-to-moderate LVDD patients.
Methods: Of the patients with mild-to-moderate LVDD (Grade I and II) with preserved left ven-
tricular ejection fraction (EF), 225 with LVH (LVH group) and 225 without LVH (non-LVH group)
were consecutively selected. LVDD was defined by the abnormal patterns of Doppler mitral
inflow and tissue Doppler. Left ventricular filling pressure (FP) was estimated by the following
formula: 1.9 þ1.24 [early mitral inflow velocity (E)/early mitral annular velocity (e’)]. The
Tei index was implemented to assess global (both systolic and diastolic) left ventricular func-
tion. Echocardiographic parameters for LVDD, such as isovolumic relaxation time (IVRT), were
compared between the two groups.
Results: FP and Tei index were significantly higher in the LVH group compared to the non-LVH
group [15.68 mmHg vs. 14.07 mmHg, P < 0.0001, and 0.58 vs. 0.53, P < 0.003, respectively].
IVRT was significantly longer in the LVH group than in the non-LVH group [103.93  23.93 vs.Health System-Albert Lea/Austin, 2002 Rivera Drive, Albert Lea, MN, 56007, USA. Tel.: þ1 507 383
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An effect of left ventricular hypertrophy 9395.94  20.16, P < 0.0001].
Conclusions: In mild-to-moderate LVDD patients, both FP and the Tei index were significantly
higher when LVH was present. This may suggest LVH as a possible predictor for the future
development of severe LVDD and diastolic heart failure.
ª 2016 Hellenic Cardiological Society. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diastolic heart failure, also known as heart failure with
preserved EF, is a clinical syndrome that accounts for
approximately half of all heart failure patients.1,2 Diastolic
heart failure is diagnosed when there are clinical symptoms
of heart failure, the presence of normal or near normal left
ventricular systolic function and evidence of left ventricle
diastolic dysfunction (LVDD).2,3 LVDD is known to have
strong associations with advanced age, female gender,
obesity, hypertension, diabetes mellitus, and left ventric-
ular hypertrophy (LVH).4e7 However, it is still unclear
whether all cases of LVDD are characteristically the same
among different aetiologies. Because the prevalence of
heart failure is increasing by approximately 1% annually,1,8
understanding the pathophysiology of LVDD is important for
identifying the high-risk group.
LVH is known to be the most common pathological con-
dition that induces LVDD, and it is associated with worsened
cardiovascular prognosis.6,8,9 However, to date, there has
been no direct comparison of the LVDD characteristics be-
tween patients with LVH and those without. We hypothe-
sized that mild-to-moderate LVDD with LVH carries a higher
risk of developing severe LVDD and diastolic heart failure
than LVDD without LVH. In this context, we studied two
LVDD groups, a mild-to-moderate LVDD with LVH group (the
LVH group) and a mild-to-moderate LVDD without LVH group
(the non-LVH group), to determine the echocardiographic
differences between the groups. We compared the patient
demographics and the echocardiographic characteristics,
including left ventricular filling pressure (FP) and the Tei
index (also known as myocardial performance index) be-
tween the two groups.
2. Methods
2.1. Data collection
The study was reviewed and approved by the Internal Re-
view Board. A total of 450 patients with an echocardio-
graphic diagnosis of LVDD (225 patients with LVH and 225
patients without LVH) were consecutively selected from our
echocardiography database.
2.2. Patient demographic profiles
Demographic profiles, laboratory values, medications, and
medical histories were obtained from the electronic health
records. Hypertension is defined as a history of hyperten-
sion requiring the current use of anti-hypertensivemedications. The blood pressure values in the study were
obtained from the echocardiogram. Coronary artery disease
(CAD) was defined as a history of a stress test that was
positive for ischemia, the presence of coronary flow-
limiting stenosis by coronary angiogram, and/or a history
of coronary revascularization. Chronic obstructive pulmo-
nary disease (COPD) was a clinical diagnosis with/without
pulmonary function testing. Diabetes mellitus was defined
according to the American Diabetes Association guide-
lines.10 Valvular heart disease was defined as the presence
of moderate to severe mitral, aortic, or tricuspid valvular
disease, or a history of valve repair/replacement.11
2.3. Exclusion criteria
Patients with atrial fibrillation, tachycardia, or myocardial
infarction within the last six months, hypertrophic cardio-
myopathy, and valvular heart diseases were excluded
because the conventional echocardiographic parameters
are known to have weak to no correlation with FP.12e14
Patients with EF less than 50% were excluded to eliminate
the effect of LV systolic dysfunction on FP.
2.4. 2D and Doppler echocardiography
All echocardiograms were performed by certified techni-
cians, and the results were stored digitally in the echo-
cardiogram database. EF was measured by the quantitative
2-dimensional biplane volumetric Simpson method from the
4- and the 2-chamber views15 by the following equation:
100 X (end diastolic volume e end systolic volume)/end
diastolic volume. The parameters for left ventricle mass,
left atrial volume and left ventricle internal diameter in
diastole obtained from the chamber quantification was
indexed for the body surface area. To assess the diastolic
parameters, the mitral inflow and the mitral annular mo-
tion velocity were measured by the Doppler studies. The
following were also assessed: peak early diastolic velocity
(E); the deceleration time from the peak of the early dia-
stolic wave to baseline (DT); the peak atrial systolic ve-
locity (A); the E/A ratio; the isovolumic contraction time
(IVCT) from the mitral valve closure to the aortic valve
opening; the ejection time (ET) from the aortic valve
opening to closure; and the isovolumic relaxation time
(IVRT) from the aortic valve closure to the mitral valve
opening. The mitral annular motion velocity was recorded
at the medial mitral annulus site in the apical 4-chamber
view by the pulsed tissue Doppler echocardiography (the
tissue Doppler). The peak early diastolic motion velocity
(e’), the peak motion velocity during atrial systole (a΄), and
94 S. Kattel et al.the ratio of the peak early diastolic transmitral flow ve-
locity E to e’ (E/e’) were also measured.
2.5. Definition of LVDD and LVH
Conventionally, abnormal relaxation is considered the
mildest form of diastolic dysfunction (grade I).16 In this
study, the presence of mitral E/A <0.75 or DT > 240 ms
was considered evidence of abnormal relaxation. In a
more severe stage of diastolic dysfunction with pseudo-
normal LV filling (grade II), the transmitral flow charac-
teristics are similar to those in patients with normal
diastolic function. However, patients with this abnormal-
ity generally have elevated FP. In this study, both pseu-
donormal and normal LV filling were defined by the
presence of mitral E/A of 0.75 to 1.50 and DT of 151 to
240 ms, but distinguished by tissue Doppler. Restrictive
diastolic filling (grade III, reversibly restrictive; grade IV,
irreversibly restrictive) is associated with markedly
elevated LV filling pressures and is the most severe form of
diastolic dysfunction.17 The presence of mitral E/A >1.5
or DT  140 ms was considered evidence of restrictive
diastolic filling. Only Grade I and II LVDD were included in
this study. The American Society of Echocardiography-
recommended formula was used to estimate LV mass
from the LV linear dimensions by 2D echo, which is based
on modelling the LV as a prolate ellipse of revolution and
indexed to the body surface area. LVH was defined by the
left ventricular mass index (g/m2) higher than 88 g/m2 in
females and 102 g/m2 in males, as proposed by the
American Society of Echocardiography.15
2.6. Tei index
The Tei index (also known as myocardial performance
index), initially described by Tei C, et al,18 is a Doppler-
derived time interval index that combines both systolic
and diastolic cardiac performance. The Tei index appears
to have close correlation with the widely accepted systolic
and diastolic hemodynamic parameters as well as potential
for the clinical application in the assessment of overall
cardiac performance.18e21 The Tei index is calculated by
the following formula: (isovolumic contraction
time þ isovolumic relaxation time)/ejection time. In
adults, a left ventricle Tei index of less than 0.4 is consid-
ered normal. The higher index values correspond to more
pathological states with overall cardiac dysfunction.
2.7. Left ventricular filling pressure (FP)
FP was estimated non-invasively from echocardiographic
parameters as described elsewhere.22e25 Briefly, FP was
calculated by the following formula: [1.24  (E/e’) þ 1.9]
where E and e’ are the early filling velocities of the mitral
inflow and the tissue Doppler, respectively.
2.8. Statistical analysis
The values were expressed as the mean  standard devia-
tion. The parametric and non-parametric data were
analyzed by independent T-test and Pearson’s Chi Squaretest, respectively using the SPSS software, version 20. All
statistical tests were two-sided, and P-value 0.01 was
used to define statistical significance.3. Results
3.1. Demographics of the study population
The demographics of the study population were summa-
rized in Table 1. Patients were older in the LVH group than
the non-LVH group (71.82  13.49 vs. 68.27  13.99;
P Z 0.006). Females and Caucasians were similarly domi-
nant in both the LVH and non-LVH groups (P Z 0.026 and
0.498, respectively). There was a difference in the preva-
lence of hypertension (P Z 0.009), and systolic blood
pressure was significantly higher in the LVH group than the
non-LVH group (136.3  20.6 mm Hg vs.
130.05  18.14 mmHg, p < 0.001). There were no statisti-
cally significant differences in the distribution of patients
with Grade I and II LVDD or other clinical characteristics
between the two groups.
3.2. Echocardiographic parameters, FP, and Tei
index
The results of echocardiographic parameters are summa-
rized in Table 2 and Figs. 1 and 2. There was no difference in
EF between the two groups (63.98  6.98% in the LVH group
and 65.14 7.31% in the non-LVH group, PZ 0.086). LVmass
index was significantly higher in the LVH group compared to
the non-LVH group (118.91 27.49 g/m2 vs. 72.47 13.74 g/
m2, P< 0.0001). LV internal diameter in diastole (LVIDd) was
greater in the LVH group compared to the non-LVH group
(4.63  0.69 cm vs. 4.10  0.58 cm; PZ 0.0001); however,
relative wall thickness (RWT) was not significantly different
between the two groups. Both groups had increased RWT,
greater than 0.42, although there was no statistically sig-
nificant difference. Compared to the non-LVH group, the LVH
group had significantly higher FP (15.68  4.50 mmHg vs.
14.07  3.03 mmHg, P < 0.0001), larger left atrial size
(3.77 0.63 vs. 3.51 0.65 cm, p< 0.0001), larger left atrial
volume index (31.82  11.38 ml/m2 vs. 24.36  9.68 ml/m2,
P < 0.0001), and longer IVRT (103.93  23.93 vs.
95.94  20.16, P < 0.0001). The Tei-index was abnormal (>
4.0) in the both groups, but significantly higher in the LVH
group than the non-LVH group (0.58  0.15 vs. 0.53  0.15,
P< 0.003), suggestingworsened global LV function in the LVH
group. There were no significant differences in other echo-
cardiographic parameters, such as pulmonary artery pres-
sure, E and A wave velocities, E/A ratio, IVCT, ET, and DT
between the two groups.
4. Discussion
LVDD is commonly observed in patients with advanced age,
female gender, obesity, diabetes mellitus, hypertension,
coronary artery disease, and LVH6,26,27. However, the clin-
ical characteristics of the above conditions are different
among patients. LVDD associated with aging and gender is
considered among “biological” changes or differences. On
Table 1 Clinical characteristics of patients.
Clinical characteristics LVH Group* Non-LVH Group* P value
Age (years) 71.82  13.498 68.27  13.995 0.006**
Female 164 (72%) 142(63%) 0.026
African American 69 (31%) 70 (31%) 0.498
Caucasian 135 (60%) 143 (63%)
Other Races 21 (9%) 12 (6%)
BMI (Kg/m2) 29.49  8.44 29.69  8.26 0.792
SBP (mmHg) 136.3  20.653 130.05  18.141 0.001**
DBP (mmHg) 70.10  11.62 70.64  10.87 0.627
Creatinine (mg/dl) 1.27  1.19 1.12  0.89 0.144
Tobacco abuse 90 (41%) 95 (45%) 0.431
COPD 49 (22%) 51(24%) 0.639
Dyslipidaemia 108 (50%) 96 (46%) 0.428
Diabetes 73 (32%) 63 (28%) 0.256
CAD 48 (22%) 42 (20%) 0.627
Hypertension 196 (88%) 167 (79%) 0.009**
ACE-I/ARB 99(44%) 97 (43%) 0.849
Diuretics 79 (35%) 73 (32%) 0.550
CCB 84 (39%) 63 (31%) 0.079
Beta-blocker 104(48%) 78 (38%) 0.030
Statins 107(49%) 91(44%) 0.251
Aspirin/Plavix 105(46%) 87(39%) 0.110
Diastolic Dysfunction grade Grade I 94 (42%) 87 (39%) 0.501
Grade II 131 (58%) 138 (61%)
*Values are expressed as the mean  1SD or numbers (%). ** P values were significant at <0.01.
BMI: body mass index; COPD: chronic obstructive pulmonary disease; CAD: coronary artery disease; ACE-I: angiotensin converting
enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker; SBP: Systolic Blood Pressure; DBP: Diastolic Blood
Pressure
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mellitus, hypertension, and/or LVH is considered among
“pathological” conditions. Our question was whether LVDD
of different aetiologies is characteristically the same. In
this report, we studied LVH-related LVDD, which is the mostTable 2 Echocardiographic characteristics of patients.
Echocardiographic Parameters LVH Group* Non
LV mass Index (g/m2) 118.91  27.49 72
LA size (cm) 3.77  0.63 3
LA Volume/BSA (ml/m2) 31.82  11.38 24
LVIDd (cm) 4.63  0.69 4
LVIDd/BSA(cm/m2) 2.47  0.37 2
Relative Wall Thickness 0.54  0.13 0
PAP (mmHg) 35.56  10.93 33
EF (%) 63.98  6.98 65
E/A 0.83  0.19 0
E/e 11.48  3.75 10.
DT (msec) 246.43  56.67 232
IVCT (msec) 61.43  21.01 56
ET (msec) 292.65  46.77 289
IVRT (msec) 103.93  23.65 95
FP (mmHg) 15.68  4.50 14
Tei index 0.58  0.15 0
*Values are expressed in Mean  1SD or numbers (%). ** P value signi
LV: left ventricle; LA: left atrium; BSA: body surface area; LVIDd: LV i
ejection fraction; E: early diastolic filling on pulse wave Doppler; A: la
excursion on tissue Doppler; DT: deceleration time; ET: ejection tim
contraction time; FP: left ventricle filling pressure.common pathological LVDD. We assessed whether LVH has
any additional effect on LV diastolic function and overall
cardiac function in mild-to-moderate LVDD patients.
In our study population, LVDD was observed more
commonly in the patients with advanced age (over 70-LVH Group* P value 95% Confidence interval
.47  13.74 0.0001** 42.61 to 50.25
.51  0.65 0.0001** 0.13 to 0.37
.36  9.68 0.0001** 5.50 to 9.42
.10  0.58 0.0001** 0.41 to 0.65
.14  0.32 0.0001** 0.25 to 0.38
.51  0.12 0.010 0.007 to 0.054
.86  8.77 0.098 0.31 to 3.71
.14  7.31 0.086 2.48 to 0.16
.83  0.19 0.775 0.041 to 0.308
283  2.83 0.0001** 0.72 to 1.95
.91  57.77 0.013 2.912 to 24.119
.14  28.70 0.026 0.63 to 9.95
.00  43.06 0.389 4.67 to 11.98
.94  20.16 0.0001** 3.91 to 12.06
.07  3.40 0.0001** 0.87 to 2.34
.53  0.15 0.003** 0.014 to 0.072
ficant at <0.01.
nternal diameter in diastole; PAP: pulmonary artery pressure; EF:
te diastolic filling on pulse wave Doppler; e: early mitral annulus
e; IVRT: isovolumic ventricular relaxation time; IVCT: isovolumic
Figure 1 Box plot for LAP.
96 S. Kattel et al.years), female gender, and obesity, as reported in previous
studies.1,6,8 The prevalence of medical conditions including
CAD, dyslipidaemia, COPD, diabetes mellitus, and hyper-
tension observed in our study groups was also similar to
previous studies,5e7 suggesting the appropriateness of our
study population.
The prevalence of hypertension including the systolic
blood pressure measured at the time of echocardiogram
was significantly higher in the LVH group than the non-LVH
group. However, this relationship was expected because
LVH is recognized as hypertensive heart disease.4,28 Both
groups had increased RWT, suggesting the concentric na-
ture of hypertrophy in the LVH group, and on the other
hand, concentric remodelling in the non-LVH group given
normal LV mass.15
The echocardiogram is a reliable tool to non-invasively
assess left ventricular systolic function, diastolic function,
and pulmonary artery pressure.29 In addition to those con-
ventional measurements, FP can also be fairly accurately
estimated from the echocardiographic parameters with
current echocardiographic parameters.23e25,30,31 Our study
demonstrated that FP was significantly higher when LVDDFigure 2 Box plot for Tei Index.was accompanied by LVH. Higher FP was also reflected by
the significantly larger left atrial size and higher left atrial
volume index (ml/m2) in the LVH group.
The Tei index assesses the overall cardiac performance,
including both the systolic and diastolic function of the
heart.18 Higher index values correspond to more patholog-
ical states with overall cardiac dysfunction. The Tei index
also carries a significant prognostic value. As Tei index in-
creases, the cardiovascular mortality increases.19e21 In our
study, the Tei index was abnormal (high) in the both groups.
This was most likely due to the presence of LVDD because
the EF was preserved in both groups. Moreover, the index
was significantly higher in the LVH group than in the non-
LVH group.
The Tei index is known to be independent of FP and the
ventricular geometry.32 Because there were no significant
differences in LV systolic function (EF) in both groups, a
higher Tei index (worsened overall LV function) was
considered solely due to worsened LV diastolic function in
the LVH group. This hypothesis is also supported by the fact
that the LVH group had significantly longer IVRT, which was
consistent with worsened LV relaxation. Because worsening
of diastolic function is an independent predictor of mor-
tality in patients with normal baseline EF,9,33 the patients
with LVDD with co-existing LVH may be at higher cardio-
vascular risk than those without LVH.
There are a few limitations in our study. Firstly, we did
not confirm FP using invasive methods. Cardiac catheteri-
zation was not indicated in most of our patients. The
echocardiographic FP estimation has a strong correlation
with invasive FP measurement.23,24 However, it has also
been reported that the non-invasive estimation of FP may
not be accurate in patients with tachycardia, mitral
valvular disease, recent myocardial infraction, and hyper-
trophic cardiomyopathy.12e14 Although those patients were
excluded from our study, validation of the echocardio-
graphic FP estimation may require invasive measurements.
Secondly, our echo laboratory usually performs tissue
Doppler for the medial mitral annulus only. The correlations
of the FP with the medial annulus measurements have been
reported to be consistent with or better than the lateral
annulus measurements or the combination of both mea-
surements.22,23 However, the LV regional wall motion ab-
normality and/or intraventricular conduction delay may
alter LV basal septal wall motion in the apical 4-chamber
view, which possibly affects the tissue Doppler measure-
ment of the medial mitral annular velocity.
Thirdly, the direct effect of higher systolic blood pres-
sure on FP and the Tei index in the LVH group cannot be
excluded. It is important to prove the higher FP and Tei
index are solely due to worsened LVDD by LVH, but not due
to higher systolic blood pressure. However, LVH is usually
the consequence of poor blood pressure control. Because of
this close correlation between LVH and hypertension, it
may be difficult to discuss these two factors separately.
Additionally, the LA volumes and size in LVH patient pop-
ulations, but not in the non-LVH population, are only
slightly abnormal; it is likely that these patient populations
exhibit an early disease process or have significant variation
among groups.
Lastly, because of the nature of any cross-sectional
study, the clinical implications of LVH, such as transition to
An effect of left ventricular hypertrophy 97more severe LVDD and the development of clinical diastolic
heart failure, remain undetermined. However, because the
presence of LVH was associated with worsened LV diastolic
function in the mild-to-moderate LVDD population, we
speculate that these patients are at higher risk of devel-
oping severe LVDD and diastolic heart failure when mild-to-
moderate LVDD is associated with LVH.
In conclusion, our study demonstrated that the patients
with mild to moderate LVDD had higher FP and worsened
global LV function with worsened LV diastolic function when
LVH co-existed. Because worsened LVDD is an independent
predictor of mortality, the patients with mild-to-moderate
LVDD may benefit from close monitoring and more aggres-
sive hypertension management when LVH co-exists. Large-
scale prospective studies are required before this concept
is validated clinically.
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